Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancer

Cancer-related fatigue (CRF) is a common symptom in breast cancer patients and survivors, which can substantially impair quality of life. Previous studies suggested that CRF may be associated with poorer survival outcomes, but had limited follow-up duration or insufficient adjustment for established...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Heumann, Philipp (VerfasserIn) , Benner, Axel (VerfasserIn) , Behrens, Sabine (VerfasserIn) , Chang-Claude, Jenny (VerfasserIn) , Seibold, Petra Beate (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 May 2025
In: Breast cancer research
Year: 2025, Jahrgang: 27, Pages: 1-9
ISSN:1465-542X
DOI:10.1186/s13058-025-02036-3
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13058-025-02036-3
Volltext
Verfasserangaben:Philipp Heumann, Axel Benner, Sabine Behrens, Jenny Chang-Claude & Petra Seibold

MARC

LEADER 00000naa a2200000 c 4500
001 1937166473
003 DE-627
005 20250929114605.0
007 cr uuu---uuuuu
008 250929s2025 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13058-025-02036-3  |2 doi 
035 |a (DE-627)1937166473 
035 |a (DE-599)KXP1937166473 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Heumann, Philipp  |d 1990-  |e VerfasserIn  |0 (DE-588)1182722466  |0 (DE-627)166287992X  |4 aut 
245 1 0 |a Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancer  |c Philipp Heumann, Axel Benner, Sabine Behrens, Jenny Chang-Claude & Petra Seibold 
264 1 |c 12 May 2025 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.09.2025 
520 |a Cancer-related fatigue (CRF) is a common symptom in breast cancer patients and survivors, which can substantially impair quality of life. Previous studies suggested that CRF may be associated with poorer survival outcomes, but had limited follow-up duration or insufficient adjustment for established prognostic factors. The aim of this analysis was to assess the prognostic value of CRF at the end of radiotherapy for overall survival in a cohort of women with breast cancer with a median follow-up time of 19 years. 
650 4 |a Breast neoplasms 
650 4 |a Fatigue 
650 4 |a Patient reported outcome measures 
650 4 |a Radiotherapy 
650 4 |a Survival 
700 1 |a Benner, Axel  |d 1959-  |e VerfasserIn  |0 (DE-588)106584686X  |0 (DE-627)81687221X  |0 (DE-576)425536602  |4 aut 
700 1 |a Behrens, Sabine  |e VerfasserIn  |0 (DE-588)1139515713  |0 (DE-627)897254988  |0 (DE-576)493340092  |4 aut 
700 1 |a Chang-Claude, Jenny  |e VerfasserIn  |0 (DE-588)1049304993  |0 (DE-627)781626188  |0 (DE-576)168344475  |4 aut 
700 1 |a Seibold, Petra Beate  |d 1981-  |e VerfasserIn  |0 (DE-588)1022470523  |0 (DE-627)71698962X  |0 (DE-576)362814635  |4 aut 
773 0 8 |i Enthalten in  |t Breast cancer research  |d London : BioMed Central, 1999  |g 27(2025), Artikel-ID 76, Seite 1-9  |h Online-Ressource  |w (DE-627)326645950  |w (DE-600)2041618-0  |w (DE-576)27922463X  |x 1465-542X  |7 nnas  |a Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancer 
773 1 8 |g volume:27  |g year:2025  |g elocationid:76  |g pages:1-9  |g extent:9  |a Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancer 
856 4 0 |u https://doi.org/10.1186/s13058-025-02036-3  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250929 
993 |a Article 
994 |a 2025 
998 |g 1049304993  |a Chang-Claude, Jenny  |m 1049304993:Chang-Claude, Jenny  |d 50000  |e 50000PC1049304993  |k 0/50000/  |p 4 
998 |g 106584686X  |a Benner, Axel  |m 106584686X:Benner, Axel  |d 50000  |e 50000PB106584686X  |k 0/50000/  |p 2 
998 |g 1182722466  |a Heumann, Philipp  |m 1182722466:Heumann, Philipp  |d 50000  |e 50000PH1182722466  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1937166473  |e 4777247899 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Philipp Heumann, Axel Benner, Sabine Behrens, Jenny Chang-Claude & Petra Seibold"]},"physDesc":[{"extent":"9 S."}],"recId":"1937166473","relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"326645950","id":{"zdb":["2041618-0"],"issn":["1465-542X"],"eki":["326645950"]},"note":["Gesehen am 29.12.2016"],"pubHistory":["1.1999 -"],"origin":[{"dateIssuedKey":"1999","publisher":"BioMed Central","dateIssuedDisp":"1999-","publisherPlace":"London"}],"title":[{"title_sort":"Breast cancer research","title":"Breast cancer research"}],"disp":"Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancerBreast cancer research","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"part":{"year":"2025","pages":"1-9","volume":"27","extent":"9","text":"27(2025), Artikel-ID 76, Seite 1-9"}}],"id":{"eki":["1937166473"],"doi":["10.1186/s13058-025-02036-3"]},"origin":[{"dateIssuedDisp":"12 May 2025","dateIssuedKey":"2025"}],"note":["Gesehen am 29.09.2025"],"title":[{"title_sort":"Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancer","title":"Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival ≥ 10 years in women with breast cancer"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"family":"Heumann","display":"Heumann, Philipp","given":"Philipp","role":"aut"},{"family":"Benner","display":"Benner, Axel","role":"aut","given":"Axel"},{"family":"Behrens","display":"Behrens, Sabine","role":"aut","given":"Sabine"},{"display":"Chang-Claude, Jenny","family":"Chang-Claude","given":"Jenny","role":"aut"},{"role":"aut","given":"Petra Beate","family":"Seibold","display":"Seibold, Petra Beate"}]} 
SRT |a HEUMANNPHIPROGNOSTIC1220